Atrial Fibrillation: Screening, Management and Outcomes

Dear Colleagues,

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia observed in clinical practice. AF is an important contributor to cardiovascular mortality as well as morbidity and can considerably reduce quality of life. Cardiovascular morbidity also occurs through an increased risk of stroke and heart failure. Recent evidence suggests that the morbidity and mortality associated with AF occur regardless of whether patients are symptomatic. This highlights the importance of screening for and detecting subclinical AF, an area with exciting developments in diagnostic tools, such as mobile technologies. The management of AF is also critical to reduce adverse cardiovascular outcomes, and there is now increasing evidence for early intervention to achieve rhythm control and prevent the progression of AF. AF ablation is an important tool for achieving rhythm control and is an area of ongoing technological advancements, including cryoablation and pulse field ablation, that aim to improve efficacy and reduce procedural complications. Finally, there has also been increasing evidence that early rhythm control, including AF ablation, can reduce adverse cardiovascular events. This Special Issue aims to provide insights into the advances in AF, with a focus on AF screening, management, and outcomes.

We look forward to receiving your submissions.

Dr. Ahmed AlTurki
Prof. Dr. Vidal Essebag
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.